June 29, 2006
NIAID Trials of Adult Male Circumcision to Continue
On June 27 and 28, the Data and Safety Monitoring Board (DSMB) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), met to review interim data from two NIAID-sponsored clinical trials of adult male circumcision to prevent HIV acquisition. The trials are being conducted in Kenya and Uganda. The DSMB analyzed the available data and recommended an additional interim analysis within the next year. At this time, there are not enough efficacy data to justify an early end to either trial. The DSMB did not identify any significant safety concerns in either trial. The trial in Uganda is scheduled to end in July 2007; the trial in Kenya is scheduled to end in September 2007.
For additional information about the trials, see Q&A: Adult Male Circumcision Trials in Kenya and Uganda
Media inquires can be directed to the NIAID OCPL media group at 301-402-1663, email@example.com.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of
infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News
releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research,
and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health ®
back to top
Last Updated June 29, 2006